Search by Drug Name or NDC

NDC 51655-0411-52 LISINOPRIL 20 mg/1 Details

LISINOPRIL 20 mg/1

LISINOPRIL is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Northwind Pharmaceuticals. The primary component is LISINOPRIL.

MedlinePlus Drug Summary

Lisinopril is used alone or in combination with other medications to treat high blood pressure in adults and children 6 years of age and older. It is used in combination with other medications to treat heart failure. Lisinopril is also used to improve survival after a heart attack. Lisinopril is in a class of medications called angiotensin-converting enzyme (ACE) inhibitors. It works by decreasing certain chemicals that tighten the blood vessels, so blood flows more smoothly and the heart can pump blood more efficiently. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 51655-0411-52
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Lisinopril

Product Information

NDC	51655-0411
Product ID	51655-411_f7e4a874-49e9-b881-e053-6394a90a7670
Associated GPIs	36100030000315
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	LISINOPRIL
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lisinopril
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	LISINOPRIL
Labeler Name	Northwind Pharmaceuticals
Pharmaceutical Class	Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA076164
Listing Certified Through	2024-12-31

Package

NDC 51655-0411-52 (51655041152)

Pricing Information	N/A
NDC Package Code	51655-411-52
Billing NDC	51655041152
Package	30 TABLET in 1 BOTTLE, PLASTIC (51655-411-52)
Marketing Start Date	2020-03-13
NDC Exclude Flag	N